latest news releases from the newsroom
Oasmia Pharmaceutical AB
Oasmia in discussions concerning acquisition of novel cancer project
Uppsala, Sweden, October 21, 2016 --- The pharmaceutical company Oasmia
Pharmaceutical AB (NASDAQ: OASM) announce today that the company is in
discussions concerning acquisition of a novel cancer project.
More information will be released on Monday at the latest.
About Oasmia Pharmaceutical AB
Oasmia Pharmaceutical AB develops, manufactures, markets and sells new
generations of drugs in the field of human and veterinary oncology. The
company’s product development aims to create and ma